Diane E. Wilfong - 10 Aug 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controller & CAO
Signature
/s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Issuer symbol
GILD
Transactions as of
10 Aug 2022
Net transactions value
-$67,307
Form type
4
Filing time
11 Aug 2022, 17:26:14 UTC
Previous filing
17 Jun 2022
Next filing
12 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +2,479 +9.3% 29,229 10 Aug 2022 Direct F1
transaction GILD Common Stock Tax liability $67,307 -1,066 -3.6% $63.14 28,163 10 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2,479 -15% 13,560 10 Aug 2022 Common Stock 2,479 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.